MetLife Small Company Equity Fund Institutional Shares MSVIX

Medalist Rating as of | See MetLife Investment Management Investment Hub
  • NAV / 1-Day Return 5.46  /  −0.73 %
  • Total Assets 7.7M
  • Adj. Expense Ratio
    0.990%
  • Expense Ratio 0.980%
  • Distribution Fee Level Above Average
  • Share Class Type Institutional
  • Category Small Blend
  • Investment Style Small Blend
  • Min. Initial Investment 100,000
  • Status Open
  • TTM Yield 0.08%
  • Turnover 90%

USD | NAV as of Jul 14, 2026 | 1-Day Return as of Jul 14, 2026, 12:11 AM GMT+0

Morningstar’s Analysis MSVIX

Will MSVIX outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

MetLife Small Company Equity Inst holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MSVIX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 17.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Cash & Cash Equivalents

4.79 337,645
Cash and Equivalents

Axsome Therapeutics Inc

1.92 135,723
Healthcare

Kontoor Brands Inc

1.89 133,410
Consumer Cyclical

Advanced Energy Industries Inc

1.81 127,470
Industrials

Littelfuse Inc

1.79 125,899
Technology

Northwest Natural Holding Co

1.75 123,204
Utilities

Plexus Corp

1.73 121,929
Technology

State Street® SPDR® S&P® Biotech ETF

1.71 120,322

Praxis Precision Medicines Inc Ordinary Shares

1.70 119,532
Healthcare

iShares Russell 2000 ETF

1.60 112,840

Sponsor Center